查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1403410

胃腸支架市場至2030年的預測：按產品類型、材料、應用、最終用戶和地區分類的全球分析

Gastrointestinal Stents Market Forecasts to 2030 - Global Analysis By Product, Type, Material, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC的資料，2023年全球胃腸支架市場規模為5.2971億美元，預計到2030年將達到8.8456億美元，預測期內年複合成長率為7.6%。

胃腸支架是醫療設備，用於治療消化器官系統內狹窄或阻塞的通道，例如食道、胃或腸。這些管狀結構透過內視鏡插入，以提供支撐、緩解阻塞並促進液體和食物的流動。胃腸支架在治療狹窄、腫瘤和阻塞等疾病方面發揮重要作用，為手術提供了一種侵入性較小的替代方案。

根據 MDPI Publishers 在《Current Oncology Research Article》上發表的2022年報告顯示，中國報告的上消化道癌症病例數為男性 14,934,040 例，女性 6,262,431 例，1990年至2019年成長率為 181.4%。

胃腸道疾病盛行率增加

由於大腸直腸癌、發炎性腸道疾病疾病和胃腸道狹窄等胃腸道疾病的盛行率不斷增加，需要有效的治療性介入，而胃腸道支架可以緩解患者的症狀，在改善預後方面發揮著重要作用。這些支架有助於恢復正常的消化功能、緩解症狀並提供微創解決方案。人們對這些疾病的認知不斷提高，加上支架技術的進步，醫療保健專業人員越來越傾向於選擇這些設備來滿足胃腸道干預需求的激增，進一步推動市場成長。

缺乏意識

對胃腸道問題和可用治療方案缺乏認知可能會導致診斷和治療的延遲。患者教育以及醫療保健提供者和患者之間的共同決策可能會受到共用，限制了胃腸道疾病管理的選擇。從市場角度來看，如果醫療保健專業人士和公眾的意識不足，製造商和供應商在促銷產品和增加市場佔有率可能會面臨挑戰。

客製化和針對患者的解決方案的興起

客製化胃腸道支架以滿足患者的個別需求可以提高治療效果並最大限度地減少潛在的併發症。這一趨勢不僅解決了獨特的解剖學差異，而且改善了患者的整體治療效果並促進了市場的創新和成長。隨著個體化醫療介入的需求不斷上升，胃腸支架領域個體化解決方案的整合被定位為進步和市場拓展的關鍵手段。

替代治療方案的可用性

患者和醫療保健提供者可以選擇支架以外的干涉措施，例如藥物治療或微創手術，減少對胃腸道支架的需求。這些不斷變化的偏好可能會影響傳統支架製造商的市場佔有率和收益潛力，需要創新、功效和其他因素才能在不斷發展的胃腸道治療領域保持競爭力，強調需要改進和策略差異化。

COVID-19 的影響

COVID-19 大流行造成供應鏈中斷、選擇性手術延遲以及危機管理醫療資源的轉移，影響了胃腸支架市場。這些因素導致胃腸支架需求暫時下降。然而，隨著醫療保健系統適應新的常態和選擇性手術的恢復，市場復甦。對內視鏡手術的日益關注和支架技術的進步也將推動胃腸支架市場的未來成長。

自膨脹金屬支架市場預計將在預測期內成為最大的市場

自膨脹金屬支架領域預計將出現良好的成長。自膨式金屬支架（SEMS）在胃腸道支架中發揮非常重要的作用，為多種病症提供微創解決方案。這些支架由金屬合金製成，在展開時自動膨脹，為阻塞或狹窄的胃腸道提供結構支撐。 SEMS 可有效緩解阻塞和狹窄等症狀，進而改善消化功能。其多功能性和適應性使其成為治療食道、結直腸和膽道阻塞等疾病的首選。

胃腸癌領域預計在預測期內年複合成長率最高

預計胃腸癌領域在預測期內年複合成長率最高。胃腸支架透過緩解症狀和改善患者的生活品質在胃腸道癌症的治療中發揮重要作用。這些支架透過內視鏡手術進行部署，提供了一種微創解決方案，可恢復正常功能並允許食物和液體通過。胃腸支架起到安寧療護的作用，提高患者的舒適度並促進治療計劃。

佔比最大的地區：

由於胃腸道疾病的發病率增加和人口老化，預計亞太地區在預測期內將佔據最大的市場佔有率。中國、日本和印度等國家對市場成長做出了巨大貢獻。它也是Boston, Medtronic and Abbott Laboratories等主要企業的所在地。對微創手術的需求以及大腸直腸癌等疾病的日益普及刺激該地區採用胃腸支架。隨著醫療基礎設施的改善和對有效胃腸道介入的需求的增加，預計該市場將繼續擴大。

年複合成長率最高的地區：

由於阻塞性胃腸道疾病的盛行率不斷增加、有利的償付政策和人口老化，預計北美在預測期內將出現最高的年複合成長率。北美是醫療設備產業最發達的市場之一。此外，由於能夠以低廉的價格提供先進的醫療服務，該地區的醫療旅遊業蓬勃發展，並且該地區的患者群體預計將擴大。

免費客製化服務：

訂閱此報告的客戶將收到以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多3家公司）
    • 主要企業SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球胃腸支架市場：依產品

  • 十二指腸支架
  • 膽管支架
  • 胰臟支架
  • 結腸支架
  • 食道支架

第6章 全球胃腸支架市場：依類型

  • 抗遷移支架
  • 放射性支架
  • 藥物釋放型支架
  • 抗逆流支架
  • 重塑支架
  • 其他類型

第7章 全球胃腸支架市場：依材料分類

  • 自膨脹金屬支架
  • 塑膠支架
  • 其他材料

第8章 全球胃腸支架市場：依應用分類

  • 胃癌
  • 大腸激躁症
  • 胰臟癌
  • 大腸直腸癌
  • 消化道癌症
  • 食道癌
  • 膽道疾病
  • 其他用途

第9章 全球胃腸支架市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第10章 全球胃腸支架市場：依地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第11章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司簡介

  • Boston Scientific Corporation
  • Hobbs Medical Inc.
  • General Electric Company
  • Cantel Medical Corporation
  • Olympus Corporation
  • Merit Medical Systems
  • Qualimed
  • Medtronic
  • Conmed Corporation
  • Terumo Corporation
  • Johnson & Johnson
  • The 3M Company
  • Smith & Nephew
  • Diagmed Healthcare
  • Medline Industries
  • Baxter
  • B. Braun Melsungen AG
  • Danaher Corporation
Product Code: SMRC24635

According to Stratistics MRC, the Global Gastrointestinal Stents Market is accounted for $529.71 million in 2023 and is expected to reach $884.56 million by 2030 growing at a CAGR of 7.6% during the forecast period. Gastrointestinal stents are medical devices used to treat narrowed or blocked passages within the digestive system, such as the esophagus, stomach, or intestines. These tubular structures are inserted endoscopically to provide support, relieve obstruction, and facilitate the flow of fluids or food. Gastrointestinal stents play a crucial role in managing conditions like strictures, tumours, or obstructions, offering a minimally invasive alternative to surgery.

According to published report of 2022 in current oncology research article of MDPI publisher, reported upper gastrointestinal cancer incidences in China were 14,934,040 cases of male and 6,262,431 cases of female with growth rate 181.44% in between 1990 to 2019.

Market Dynamics:

Driver:

Increasing prevalence of gastrointestinal disorders

The escalating prevalence of gastrointestinal disorders, such as colorectal cancer, inflammatory bowel disease, and gastrointestinal strictures necessitates effective therapeutic interventions, where gastrointestinal stents play a crucial role in providing relief and improving patient outcomes. These stents facilitate the restoration of normal digestive function, alleviate symptoms, and offer minimally invasive solutions. The growing awareness of these disorders, coupled with advancements in stent technologies, further propels market growth as healthcare professionals increasingly opt for these devices to address the surging demand for gastrointestinal interventions.

Restraint:

Lack of awareness

Lack of awareness about gastrointestinal issues and available treatment options may lead to delayed diagnosis and treatment. It can hinder patient education and shared decision-making between healthcare providers and patients, limiting the choices available for managing gastrointestinal conditions. From a market perspective, manufacturers and suppliers may face challenges in promoting their products and expanding their market share if there is insufficient awareness among both healthcare professionals and the general public.

Opportunity:

Rising customized & patient-specific solutions

Tailoring gastrointestinal stents to individual patient needs enhances treatment efficacy and minimizes potential complications. This trend not only addresses unique anatomical variations but also improves overall patient outcomes, driving innovation and growth within the market. As demand for personalized medical interventions continues to rise, the integration of customized solutions in the gastrointestinal stents sector positions itself as a key avenue for advancement and market expansion.

Threat:

Availability of alternative treatment options

Patients and healthcare providers may opt for non-stent interventions, such as medications or minimally invasive procedures, reducing the demand for gastrointestinal stents. This shift in preferences could impact the market share and revenue potential for traditional stent manufacturers, emphasizing the need for innovation, improved efficacy, and strategic differentiation to maintain a competitive edge in the evolving landscape of gastrointestinal treatments.

COVID-19 Impact

The COVID-19 pandemic has impacted the Gastrointestinal Stents Market by causing disruptions in the supply chain, delaying elective procedures, and diverting healthcare resources to manage the crisis. These factors have led to a temporary decline in the demand for gastrointestinal stents. However, as healthcare systems adapt to the new normal and elective procedures resume, the market has recovered. The increased focus on endoscopic procedures and advancements in stent technology also drive future growth in the gastrointestinal stents market.

The self-expanding metal stents segment is expected to be the largest during the forecast period

The self-expanding metal stents segment is estimated to have a lucrative growth. Self-expanding metal stents (SEMS) play a pivotal role in Gastrointestinal Stents, offering a minimally invasive solution for various conditions. Composed of metal alloys, these stents automatically expand upon deployment, providing structural support to obstructed or narrowed gastrointestinal passages. SEMS effectively alleviate symptoms, such as blockages or strictures, enabling improved digestive function. Their versatility and adaptability make them a preferred choice for treating conditions like esophageal, colorectal, and biliary obstructions.

The gastrointestinal cancers segment is expected to have the highest CAGR during the forecast period

The gastrointestinal cancers segment is anticipated to witness the highest CAGR growth during the forecast period. Gastrointestinal stents play a crucial role in managing gastrointestinal cancers by alleviating symptoms and improving the quality of life for patients. Deployed through endoscopic procedures, these stents provide a minimally invasive solution, restoring proper functioning and enabling the passage of food and fluids. Gastrointestinal stents serve as palliative care, enhancing patient comfort and facilitating treatment plans.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the rising gastrointestinal disorders and an aging population. Countries like China, Japan, and India are prominent contributors to the market's growth. It is home for major key players such as Boston, Medtronic and Abbott Laboratories. The demand for minimally invasive procedures and a growing prevalence of diseases such as colorectal cancer are fueling the adoption of gastrointestinal stents in the region. The market is poised for continued expansion as healthcare infrastructure improves and the need for effective gastrointestinal interventions rises.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to the increasing prevalence of obstructive gastrointestinal diseases, favourable reimbursement policies and aging population. North America is one of the most developed medical device industries market. Further, the booming medical tourism industry in the region owing to availability of the advanced medical treatments at a cheaper cost is anticipated to expand the patient base in the region.

Key players in the market:

Some of the key players profiled in the Gastrointestinal Stents Market include Boston Scientific Corporation, Hobbs Medical Inc., General Electric Company, Cantel Medical Corporation, Olympus Corporation, Merit Medical Systems, Qualimed, Medtronic, Conmed Corporation, Terumo Corporation, Johnson & Johnson, The 3M Company, Smith & Nephew, Diagmed Healthcare, Medline Industries, Baxter, B. Braun Melsungen AG and Danaher Corporation.

Key Developments:

In November 2020, Boston Scientific Corporation (US) has received 510(k) approval from the U.S. Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex Fully Covered Esophageal Stent for the treatment of malignant esophageal strictures caused by esophageal cancer.

In October 2020, Olympus Corporation (Japan) launched HANAROSTENT Esophagus TTS Self-expanding Metal Stents (SEMS) made by MI-Tech and distributed exclusively through Olympus in the US.

Products Covered:

  • Duodenal Stent
  • Biliary Stent
  • Pancreatic Stent
  • Colonic Stent
  • Esophageal Stent

Types Covered:

  • Anti-Migratory Stents
  • Radioactive Stents
  • Drug-Eluting Stents
  • Anti-Reflux Stents
  • Shape-Modified Stents
  • Other Types

Materials Covered:

  • Self-Expanding Metal Stents
  • Plastic Stents
  • Other Materials

Applications Covered:

  • Stomach Cancer
  • Irritable Bowel Syndrome
  • Pancreatic Cancer
  • Colorectal Cancer
  • Gastrointestinal Cancers
  • Esophageal Cancer
  • Biliary Diseases
  • Other Applications

End Users Covered:

  • Ambulatory Surgical Centers
  • Hospitals
  • Specialty Clinics

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Gastrointestinal Stents Market, By Product

  • 5.1 Introduction
  • 5.2 Duodenal Stent
  • 5.3 Biliary Stent
  • 5.4 Pancreatic Stent
  • 5.5 Colonic Stent
  • 5.6 Esophageal Stent

6 Global Gastrointestinal Stents Market, By Type

  • 6.1 Introduction
  • 6.2 Anti-Migratory Stents
  • 6.3 Radioactive Stents
  • 6.4 Drug-Eluting Stents
  • 6.5 Anti-Reflux Stents
  • 6.6 Shape-Modified Stents
  • 6.7 Other Types

7 Global Gastrointestinal Stents Market, By Material

  • 7.1 Introduction
  • 7.2 Self-Expanding Metal Stents
  • 7.3 Plastic Stents
  • 7.4 Other Materials

8 Global Gastrointestinal Stents Market, By Application

  • 8.1 Introduction
  • 8.2 Stomach Cancer
  • 8.3 Irritable Bowel Syndrome
  • 8.4 Pancreatic Cancer
  • 8.5 Colorectal Cancer
  • 8.6 Gastrointestinal Cancers
  • 8.7 Esophageal Cancer
  • 8.8 Biliary Diseases
  • 8.9 Other Applications

9 Global Gastrointestinal Stents Market, By End User

  • 9.1 Introduction
  • 9.2 Ambulatory Surgical Centers
  • 9.3 Hospitals
  • 9.4 Specialty Clinics

10 Global Gastrointestinal Stents Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Boston Scientific Corporation
  • 12.2 Hobbs Medical Inc.
  • 12.3 General Electric Company
  • 12.4 Cantel Medical Corporation
  • 12.5 Olympus Corporation
  • 12.6 Merit Medical Systems
  • 12.7 Qualimed
  • 12.8 Medtronic
  • 12.9 Conmed Corporation
  • 12.10 Terumo Corporation
  • 12.11 Johnson & Johnson
  • 12.12 The 3M Company
  • 12.13 Smith & Nephew
  • 12.14 Diagmed Healthcare
  • 12.15 Medline Industries
  • 12.16 Baxter
  • 12.17 B. Braun Melsungen AG
  • 12.18 Danaher Corporation

List of Tables

  • Table 1 Global Gastrointestinal Stents Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Gastrointestinal Stents Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Gastrointestinal Stents Market Outlook, By Duodenal Stent (2021-2030) ($MN)
  • Table 4 Global Gastrointestinal Stents Market Outlook, By Biliary Stent (2021-2030) ($MN)
  • Table 5 Global Gastrointestinal Stents Market Outlook, By Pancreatic Stent (2021-2030) ($MN)
  • Table 6 Global Gastrointestinal Stents Market Outlook, By Colonic Stent (2021-2030) ($MN)
  • Table 7 Global Gastrointestinal Stents Market Outlook, By Esophageal Stent (2021-2030) ($MN)
  • Table 8 Global Gastrointestinal Stents Market Outlook, By Type (2021-2030) ($MN)
  • Table 9 Global Gastrointestinal Stents Market Outlook, By Anti-Migratory Stents (2021-2030) ($MN)
  • Table 10 Global Gastrointestinal Stents Market Outlook, By Radioactive Stents (2021-2030) ($MN)
  • Table 10 Global Gastrointestinal Stents Market Outlook, By Drug-Eluting Stents (2021-2030) ($MN)
  • Table 12 Global Gastrointestinal Stents Market Outlook, By Anti-Reflux Stents (2021-2030) ($MN)
  • Table 13 Global Gastrointestinal Stents Market Outlook, By Shape-Modified Stents (2021-2030) ($MN)
  • Table 14 Global Gastrointestinal Stents Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 15 Global Gastrointestinal Stents Market Outlook, By Material (2021-2030) ($MN)
  • Table 16 Global Gastrointestinal Stents Market Outlook, By Self-Expanding Metal Stents (2021-2030) ($MN)
  • Table 17 Global Gastrointestinal Stents Market Outlook, By Plastic Stents (2021-2030) ($MN)
  • Table 18 Global Gastrointestinal Stents Market Outlook, By Other Materials (2021-2030) ($MN)
  • Table 19 Global Gastrointestinal Stents Market Outlook, By Application (2021-2030) ($MN)
  • Table 20 Global Gastrointestinal Stents Market Outlook, By Stomach Cancer (2021-2030) ($MN)
  • Table 21 Global Gastrointestinal Stents Market Outlook, By Irritable Bowel Syndrome (2021-2030) ($MN)
  • Table 22 Global Gastrointestinal Stents Market Outlook, By Pancreatic Cancer (2021-2030) ($MN)
  • Table 23 Global Gastrointestinal Stents Market Outlook, By Colorectal Cancer (2021-2030) ($MN)
  • Table 24 Global Gastrointestinal Stents Market Outlook, By Gastrointestinal Cancers (2021-2030) ($MN)
  • Table 25 Global Gastrointestinal Stents Market Outlook, By Esophageal Cancer (2021-2030) ($MN)
  • Table 26 Global Gastrointestinal Stents Market Outlook, By Biliary Diseases (2021-2030) ($MN)
  • Table 27 Global Gastrointestinal Stents Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 28 Global Gastrointestinal Stents Market Outlook, By End User (2021-2030) ($MN)
  • Table 29 Global Gastrointestinal Stents Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 30 Global Gastrointestinal Stents Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 31 Global Gastrointestinal Stents Market Outlook, By Specialty Clinics (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.